MedCity News

SEPTEMBER 13, 2022

Gen Z MSLs have the skills and power to change the future of healthcare by using technology to redefine who KOLs are, how they are engaged, and ultimately, how clinical trials are run – and with it the potential to make health equity a reality. Gen Z is the most diverse, digitally-proficient generation yet.

Medical science 86

Medical science Healthcare Healthcare Medical 86

Clarivate

MARCH 8, 2023

In recent years, there has been an increased focus on real world evidence to advance medical science and improve patient quality of life. Biopharma companies are investing in the use of real world data (RWD) to accelerate innovation.

Patients 59

Patients Biopharma Medical science Electronics 59

Medico Reach

AUGUST 1, 2022

Whether you are a start-up looking for investment or are interested in working in venture capital (VC), the worldwide biopharma and MedTech industries are growing. In 2022, over $14 billion was funded in biopharma setup globally, and 37 major IPOs of VC-backed biotech company businesses raised a combined $4.2 New Enterprise Associates.

Biopharma 52

Biopharma Healthcare Healthcare Specialization 52

pharmaphorum

DECEMBER 23, 2022

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). With these silos breaking down, biopharmas will have the opportunity to drive a more coordinated approach to HCP engagement using shared data and unified systems, while still maintaining compliance.

Marketing 87

Marketing Sales Medical Patients 87

PM360

NOVEMBER 21, 2022

Combined with the incentives provided by the Orphan Drug Act, a powerful dynamic is at play, ever further pushing the limits of what medical science can achieve. It’s also in these communities where biopharma finds the best opportunities to connect with their stakeholders. Accelerating the Path to Diagnosis and Treatment.

Patients 52

Patients Medicine Biopharma Media 52

Clarify Health

MAY 19, 2020

There is also a looming, time-sensitive reality that biopharma companies face once their products hit the market: they need to recoup the costs of development as quickly as possible before drug patents expire and generics threaten sales. sales, medical science liaisons, etc.).

Biopharma 52

Biopharma Physicians Marketing Prescription 52

Medgadget

MARCH 22, 2023

This year it is scheduled for May 16-18, 2023 in Tel Aviv, and topics range from medical robotics, to bio-convergence, to the impact of AI on biopharma. Hundreds of Israeli life science firms will be showing off their products and technologies to attendees from all over the world.

Patients 79

Patients Medical science Leads Medical 79